We are live on
!
Find out more
Voloridge Investment Management Portfolio holdings
AUM
$25B
1-Year Est. Return
28.08%
This Fund
S&P 500
This Quarter
Est. Return
+7.29%
1 Year Est. Return
+28.08%
3 Year Est. Return
+85.2%
5 Year Est. Return
+73.43%
10 Year Est. Return
+582.16%
AUM
$21.2B
AUM Growth
+$1.07B
(+5.3%)
Cap. Flow
+$224M
Cap. Flow
% of AUM
1.06%
Top 10 Holdings %
Top 10 Hldgs %
9.44%
Holding
1,639
New
311
Increased
467
Reduced
550
Closed
311
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$211M |
| 2 |
AbbVie
ABBV
|
+$176M |
| 3 |
Apple
AAPL
|
+$170M |
| 4 |
Nike
NKE
|
+$161M |
| 5 |
Coca-Cola
KO
|
+$141M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Accenture
ACN
|
+$221M |
| 2 |
Medtronic
MDT
|
+$163M |
| 3 |
UnitedHealth
UNH
|
+$148M |
| 4 |
Johnson & Johnson
JNJ
|
+$133M |
| 5 |
Pfizer
PFE
|
+$126M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.66% |
| 2 | Consumer Discretionary | 14.98% |
| 3 | Healthcare | 13.91% |
| 4 | Financials | 10.93% |
| 5 | Industrials | 10.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1076
Trustmark
TRMK
$2.8B
| $1.26M | 0.01% |
59,777
+8,596
| +17% | +$194K |
|
1077
DexCom
DXCM
$34.5B
| $1.25M | 0.01% |
9,732
-71,922
| -88% | -$8.7M |
|
1078
Warner Music
WMG
$13.3B
| $1.25M | 0.01% |
47,764
+26,545
| +125% | +$735K |
|
|
INFN
1079
DELISTED
Infinera Corporation Common Stock
INFN
| $1.25M | 0.01% |
257,887
-544,066
| -68% | -$2.99M |
|
1080
Galicia Financial Group
GGAL
$7.23B
| $1.23M | 0.01% |
71,617
-12,680
| -15% | -$165K |
|
|
JBTM
1081
JBT Marel
JBTM
$6.1B
| $1.23M | 0.01% |
10,144
-11,537
| -53% | -$1.27M |
|
1082
HEICO Corp Class A
HEI.A
$38.1B
| $1.22M | 0.01% |
8,669
+565
| +7% | +$75.7K |
|
1083
Arcturus Therapeutics
ARCT
$223M
| $1.2M | 0.01% |
+42,007
| New | +$1.14M |
|
|
NXGN
1084
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $1.2M | 0.01% |
73,710
+32,065
| +77% | +$531K |
|
1085
Onto Innovation
ONTO
$20.6B
| $1.19M | 0.01% |
+10,229
| New | +$976K |
|
1086
SLM Corp
SLM
$5.22B
| $1.19M | 0.01% |
72,880
-107,375
| -60% | -$1.63M |
|
1087
McGrath RentCorp
MGRC
$2.94B
| $1.18M | 0.01% |
12,801
+2,945
| +30% | +$269K |
|
1088
Health Catalyst
HCAT
$132M
| $1.18M | 0.01% |
94,674
-134,686
| -59% | -$1.6M |
|
1089
Prologis
PLD
$134B
| $1.18M | 0.01% |
9,625
-12,791
| -57% | -$1.57M |
|
1090
Credicorp
BAP
$29.8B
| $1.18M | 0.01% |
+7,975
| New | +$1.09M |
|
|
ATSG
1091
DELISTED
Air Transport Services Group
ATSG
| $1.18M | 0.01% |
+62,382
| New | +$1.16M |
|
|
OSG
1092
Octave Specialty Group
OSG
$212M
| $1.18M | 0.01% |
82,582
-32,529
| -28% | -$476K |
|
1093
Ligand Pharmaceuticals
LGND
$5.76B
| $1.17M | 0.01% |
16,211
-8,045
| -33% | -$604K |
|
1094
Interactive Brokers
IBKR
$41.4B
| $1.16M | 0.01% |
56,080
-273,764
| -83% | -$5.4M |
|
1095
NetEase
NTES
$78.5B
| $1.15M | 0.01% |
+11,935
| New | +$1.08M |
|
|
VBTX
1096
DELISTED
Veritex Holdings
VBTX
| $1.15M | 0.01% |
64,352
-2,561
| -4% | -$45.6K |
|
1097
Korn Ferry
KFY
$4.36B
| $1.15M | 0.01% |
23,274
-59,359
| -72% | -$2.92M |
|
1098
Community Health Systems
CYH
$419M
| $1.14M | 0.01% |
259,562
-288,389
| -53% | -$1.23M |
|
1099
Harley-Davidson
HOG
$2.9B
| $1.14M | 0.01% |
+32,405
| New | +$1.13M |
|
1100
BRC Group Holdings
RILY
$303M
| $1.12M | 0.01% |
24,458
-55,228
| -69% | -$1.94M |
|
Similar funds
JG
OAG
WP
Voloridge Investment Management's Q2 2023 Portfolio in Review
As of Q2 2023, Voloridge Investment Management held 1,639 positions worth $21.2B, up 5.3% from $20.1B the previous quarter. Its ten largest holdings account for 9.4% of the portfolio.
Voloridge Investment Management's Q2 2023 filing shows 311 new, 467 increased, 550 reduced and 311 closed positions. Its largest new stake was Berkshire Hathaway Class B: 646,010 shares worth $220M. The largest sale was Accenture, an estimated $221M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Voloridge Investment Management's largest Q2 2023 buy was Berkshire Hathaway Class B: 646,010 shares worth $220M.
- Voloridge Investment Management added most to Coca-Cola in Q2 2023, an estimated $141M increase.
- Voloridge Investment Management's biggest Q2 2023 reduction was Medtronic, cutting an estimated $163M.
- Voloridge Investment Management fully exited Accenture in Q2 2023, selling an estimated $221M.
- Voloridge Investment Management's ten largest holdings make up 9.4% of its $21.2B portfolio in Q2 2023.
- Voloridge Investment Management opened 311 new positions and closed 311 in Q2 2023.
- Voloridge Investment Management's portfolio value rose 5.3% quarter-over-quarter to $21.2B.
Based on Voloridge Investment Management's 13F filing for Q2 2023, filed 14 Aug 2023.